First Time Loading...

BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 30.1 USD 0.43% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

-602.9m
-14%
Operating Cash Flow
Growth Rates:
1 Year
-50%
3 Years
-29%
5 Years
-
7 Years
-
10 Years
-
64.5m
+19%
Investing Cash Flow
Growth Rates:
1 Year
-80%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
580.8m
+29%
Financing Cash Flow
Growth Rates:
1 Year
+323%
3 Years
+4%
5 Years
-
7 Years
-
10 Years
-

Cash Flow Statement
BridgeBio Pharma Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
(271)
(331)
(289)
(323)
(385)
(455)
(505)
(572)
(538)
(569)
(586)
(617)
(517)
(496)
(485)
(426)
(584)
(623)
(653)
(547)
Depreciation & Amortization
0
1
0
0
0
0
0
0
4
4
6
8
5
7
7
7
7
7
6
6
Stock-Based Compensation
12
17
21
29
44
56
58
82
94
92
100
90
88
90
92
89
88
93
109
0
Other Non-Cash Items
12
25
46
47
65
80
91
114
120
115
84
91
(4)
(17)
24
10
105
126
114
99
Cash Interest Paid
4
6
6
7
8
15
15
22
22
30
30
40
44
49
54
58
58
58
61
74
Change in Working Capital
13
9
(11)
(3)
22
(4)
15
(8)
(56)
(10)
(1)
11
70
47
34
6
(13)
(5)
5
(162)
Cash from Operating Activities
(246)
N/A
(296)
-20%
(254)
+14%
(278)
-10%
(298)
-7%
(380)
-27%
(400)
-5%
(467)
-17%
(470)
-1%
(460)
+2%
(498)
-8%
(508)
-2%
(447)
+12%
(460)
-3%
(419)
+9%
(403)
+4%
(486)
-21%
(496)
-2%
(528)
-6%
(603)
-14%
Investing Cash Flow
Capital Expenditures
(6)
(6)
(5)
(7)
(7)
(7)
(8)
(5)
(7)
(13)
(13)
(12)
(14)
(8)
(6)
(5)
(2)
(2)
(1)
(3)
Other Items
0
(200)
(212)
(170)
(298)
(146)
(45)
(368)
(237)
(127)
(188)
232
383
465
459
332
183
74
55
67
Cash from Investing Activities
(9)
N/A
(206)
-2 225%
(217)
-5%
(177)
+19%
(305)
-73%
(153)
+50%
(53)
+65%
(373)
-604%
(244)
+35%
(140)
+43%
(201)
-44%
220
N/A
369
+68%
457
+24%
453
-1%
327
-28%
181
-45%
72
-60%
54
-25%
64
+19%
Financing Cash Flow
Net Issuance of Common Stock
431
821
369
295
296
(92)
(61)
(27)
(30)
(170)
(180)
(138)
(136)
4
8
152
153
464
459
632
Net Issuance of Debt
73
73
37
587
567
567
550
748
754
754
1 080
332
305
305
(20)
0
0
0
0
(23)
Other
(30)
(53)
(7)
(42)
(12)
11
(42)
(164)
(170)
(168)
(164)
(6)
0
(3)
(1)
6
4
(1)
(8)
(28)
Cash from Financing Activities
474
N/A
842
+77%
399
-53%
840
+111%
850
+1%
486
-43%
447
-8%
556
+24%
554
0%
416
-25%
736
+77%
188
-74%
169
-10%
306
+81%
(13)
N/A
137
N/A
157
+14%
462
+195%
452
-2%
581
+29%
Change in Cash
Net Change in Cash
219
N/A
339
+55%
(72)
N/A
384
N/A
247
-36%
(47)
N/A
(6)
+88%
(284)
-5 049%
(160)
+44%
(184)
-15%
38
N/A
(100)
N/A
92
N/A
303
+231%
21
-93%
61
+197%
(148)
N/A
38
N/A
(22)
N/A
42
N/A
Free Cash Flow
Free Cash Flow
(252)
N/A
(302)
-20%
(259)
+14%
(286)
-10%
(305)
-7%
(387)
-27%
(407)
-5%
(472)
-16%
(477)
-1%
(473)
+1%
(511)
-8%
(520)
-2%
(460)
+11%
(468)
-2%
(426)
+9%
(409)
+4%
(488)
-19%
(498)
-2%
(529)
-6%
(606)
-14%

See Also

Summary
BBIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
BBIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BBIO stock valuation using valuation multiples.
Wall Street Estimates
BBIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BBIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.